• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Impax Labs/Global

Anonymous board for Impax Labs/Global
Replies
2K
Views
169K
Replies
16
Views
8K
anonymous
Replies
3
Views
455
anonymous
Replies
10
Views
897
anonymous
Replies
0
Views
292
anonymous
Replies
12
Views
3K
anonymous
Replies
25
Views
8K
anonymous
Replies
8
Views
6K
anonymous
Replies
0
Views
1K
anonymous
Replies
1
Views
1K
anonymous
Replies
2
Views
2K
anonymous
Replies
4
Views
4K
anonymous
Replies
24
Views
10K
anonymous
Replies
3
Views
2K
anonymous
Replies
0
Views
1K
anonymous
Replies
16
Views
7K
anonymous
Replies
5
Views
4K
anonymous
Replies
1
Views
2K
anonymous